PhRMA Blog
2,136 FOLLOWERS
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
PhRMA Blog
21h ago
Join @PhRMA’s @lreilly71 for @WTOP’s Health Care Agenda 2024 webinar to hear about the latest in groundbreaking biopharmaceutical innovation and the urgent policy reform needed to hold PBMs accountable. Register here to watch on November 21 ..read more
PhRMA Blog
1w ago
New research from @Health_Affairs examines how the IRA impacts post-approval R&D that has been pivotal in the fight against cancer. We know what’s wrong with the law. Now lawmakers need to fix it ..read more
PhRMA Blog
1w ago
We continue to have serious concerns about persistent and often illegal abuse of 340B, which is driving up costs for patients, employers and taxpayers. Read our statement here ..read more
PhRMA Blog
1w ago
Congress should make sure savings on medicines go to patients, not PBMs ..read more
PhRMA Blog
3w ago
A new @WHO report puts a spotlight on yet another downstream benefit of vaccines – their ability to lower antibiotic use, decrease resources spent treating resistant infections and reduce the global burden of antimicrobial resistance. Learn more: #AMR ..read more
PhRMA Blog
3w ago
Our Chief Medical Officer @mybarra recently participated in the @CDCgov's Advisory Committee on Immunization Practices. See the key takeaways here about what was discussed ..read more
PhRMA Blog
3w ago
According to the latest Patient Experience Survey, out-of-pocket costs lead key health care priorities ahead of the November election. Read more ..read more
PhRMA Blog
3w ago
Today, new medicines allow for better, more targeted treatments of breast cancer. We need to preserve the system that enables this R&D by removing the obstacles that are keeping science from moving forward. More from @EA_Carpenter in @pharmaboardroom ..read more
PhRMA Blog
1M ago
When it comes to health care, voters are calling for meaningful solutions – starting with holding big insurers and their PBM middlemen accountable. Read our new blog for the latest insights into voters’ priorities ..read more
PhRMA Blog
1M ago
Blood cancers like leukemia, lymphoma and myeloma account for more than 9% of all U.S. #cancer deaths. The need to develop new treatment options is urgent, but price-setting policies in the IRA are jeopardizing this critical R&D pipeline. Here's how ..read more